Neuberger Berman Group LLC Adaptive Biotechnologies Corp Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 108,526 shares of ADPT stock, worth $616,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares

108,526

Previous 105,203 3.16%

Holding current value

$616,427

Previous $380,000 46.05%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $11,198 - $17,013	3,323 Added 3.16%	108,526 $555,000
Q2 2024 Nov 14, 2024	BUY	$2.34 - $3.96 $10,293 - $17,420	4,399 Added 4.36%	105,203 $380,000
Q2 2024 Aug 13, 2024	BUY	$2.34 - $3.96 $10,293 - $17,420	4,399 Added 4.36%	105,203 $380,000
Q1 2024 Nov 14, 2024	SELL	$2.88 - $4.8 $140,808 - $234,681	-48,892 Reduced 32.66%	100,804 $323,000
Q1 2024 May 13, 2024	BUY	$2.88 - $4.8 $290,315 - $483,859	100,804 New	100,804 $323,000
Q4 2023 Nov 14, 2024	BUY	$3.46 - $5.33 $153,945 - $237,147	44,493 Added 42.29%	149,696 $733,000
Q4 2023 Feb 09, 2024	SELL	$3.46 - $5.33 $947,244 - $1.46 Million	-273,770 Reduced 64.65%	149,696 $733,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $665,746 - $1.11 Million	-131,311 Reduced 23.67%	423,466 $2.31 Million
Q2 2023 Aug 11, 2023	SELL	$6.19 - $8.78 $420,065 - $595,828	-67,862 Reduced 10.9%	554,777 $3.72 Million
Q1 2023 May 12, 2023	SELL	$7.8 - $10.11 $64,194 - $83,205	-8,230 Reduced 1.3%	622,639 $5.5 Million
Q4 2022 Feb 13, 2023	BUY	$6.26 - $9.34 $333,094 - $496,981	53,210 Added 9.21%	630,869 $4.82 Million
Q3 2022 Nov 15, 2022	BUY	$6.5 - $12.67 $384,169 - $748,835	59,103 Added 11.4%	577,659 $4.11 Million
Q2 2022 Aug 15, 2022	SELL	$6.4 - $14.73 $4.8 Million - $11 Million	-749,517 Reduced 59.11%	518,556 $4.2 Million
Q1 2022 May 13, 2022	SELL	$10.12 - $28.9 $7.43 Million - $21.2 Million	-734,571 Reduced 36.68%	1,268,073 $17.5 Million
Q4 2021 Feb 11, 2022	SELL	$25.17 - $36.85 $6.32 Million - $9.25 Million	-251,084 Reduced 11.14%	2,002,644 $56.1 Million
Q3 2021 Nov 12, 2021	BUY	$30.02 - $39.87 $1.56 Million - $2.07 Million	51,843 Added 2.35%	2,253,728 $76.5 Million
Q2 2021 Aug 13, 2021	BUY	$32.22 - $44.59 $3.19 Million - $4.42 Million	99,140 Added 4.71%	2,201,885 $89.8 Million
Q1 2021 May 13, 2021	BUY	$37.26 - $67.74 $3.48 Million - $6.33 Million	93,441 Added 4.65%	2,102,745 $84.6 Million
Q4 2020 Feb 10, 2021	BUY	$45.01 - $65.47 $7.26 Million - $10.6 Million	161,352 Added 8.73%	2,009,304 $119 Million
Q3 2020 Nov 12, 2020	BUY	$35.79 - $48.81 $4.46 Million - $6.08 Million	124,605 Added 7.23%	1,847,952 $89.9 Million
Q2 2020 Aug 13, 2020	BUY	$24.95 - $48.38 $30.6 Million - $59.3 Million	1,225,502 Added 246.16%	1,723,347 $83.4 Million
Q1 2020 May 14, 2020	BUY	$16.96 - $34.16 $8.44 Million - $17 Million	497,845 New	497,845 $13.8 Million

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $812M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Adaptive Biotechnologies Corp Transaction History